CHILDHOOD LYMPHOBLASTIC LYMPHOMA

Clinical trials for CHILDHOOD LYMPHOBLASTIC LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new CHILDHOOD LYMPHOBLASTIC LYMPHOMA trials appear

Sign up with your email to follow new studies for CHILDHOOD LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Doctors watch for blood clot risks in Kids' cancer treatment

Knowledge-focused Recruiting now

This study aims to understand how a leukemia drug called calaspargase pegol affects the blood's ability to clot in children and young adults. Researchers will observe 15 patients aged 2-21 who are already scheduled to receive this drug as part of their standard cancer treatment. …

Matched conditions: CHILDHOOD LYMPHOBLASTIC LYMPHOMA

Sponsor: Mayo Clinic • Aim: Knowledge-focused

Last updated Mar 27, 2026 12:41 UTC

CHILDHOOD LYMPHOBLASTIC LYMPHOMA

Get alerted when new CHILDHOOD LYMPHOBLASTIC LYMPHOMA trials appear

Doctors watch for blood clot risks in Kids' cancer treatment